Spectros 140IU Spectrum Pharmaceuticals

£432.00

Spectros 140IU Spectrum Pharmaceuticals is a triptorelin acetate research compound supplied as pharmaceutical-grade injection vials for laboratory analysis and in-vitro studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Spectros 140IU Spectrum Pharmaceuticals
Spectros 140IU Spectrum Pharmaceuticals
£432.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research-Grade Triptorelin Acetate Overview

Spectros 140IU Spectrum Pharmaceuticals is a triptorelin acetate formulation manufactured for laboratory research applications. Triptorelin acetate is a synthetic analogue of gonadotropin-releasing hormone (GnRH) that belongs to the class of luteinizing hormone-releasing hormone (LHRH) agonists. This compound demonstrates high binding affinity for GnRH receptors in preclinical models, making it valuable for researchers investigating hypothalamic-pituitary-gonadal axis mechanisms. The 140IU formulation provides standardised dosing for consistent experimental protocols. Researchers studying endocrine disruption pathways and hormone regulation cascades frequently utilise Stroid UK Shop like triptorelin acetate to examine receptor binding kinetics and downstream signalling effects in cellular assays.

Laboratory Investigation Applications

Research scientists investigating reproductive endocrinology employ triptorelin acetate to study GnRH receptor dynamics and associated intracellular pathways. This compound serves as a valuable tool in cell culture experiments examining luteinizing hormone and follicle-stimulating hormone release mechanisms. Laboratories researching hormone-dependent cellular proliferation models analyse triptorelin’s effects on various tissue types including prostate, breast, and endometrial cell lines. Academic institutions studying triptorelin acetate formulations examine its receptor selectivity profile and duration of action in controlled experimental conditions. Pharmaceutical development teams utilise this compound as a reference standard when developing novel GnRH analogues. Research applications extend to investigating desensitisation mechanisms where chronic exposure leads to receptor downregulation. Comparative studies between different LHRH agonists frequently include triptorelin acetate as a benchmark compound for evaluating potency and efficacy profiles.

Product Specifications

Spectros 140IU Technical Data
Parameter Specification
Active Ingredient Triptorelin Acetate
Potency 140IU per vial
Formulation Lyophilised powder
Manufacturer Spectrum Pharmaceuticals
Storage Requirements 2-8°C refrigerated
Reconstitution Sterile water for injection
Stability 36 months unopened
CAS Number Verify with supplier

Laboratories requiring additional research compounds can explore our comprehensive SARM collections and peptide research materials for complementary experimental protocols.

Research Compliance Statement

Spectros 140IU Spectrum Pharmaceuticals triptorelin acetate is manufactured exclusively for in-vitro research purposes and laboratory analytical applications. This product is not intended for human consumption, therapeutic use, or any form of in-vivo administration. Researchers must maintain appropriate biosafety protocols when handling this compound and ensure compliance with institutional review board guidelines. All experimental protocols should follow established laboratory safety procedures and regulatory frameworks governing research chemical handling. Purchase and use of this product constitutes acknowledgement of its research-only designation and acceptance of associated handling responsibilities within accredited laboratory environments.

Related